167 related articles for article (PubMed ID: 37978457)
1. The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study.
Crook P; Logan C; Mazzella A; Wake RM; Cusinato M; Yau T; Ong YE; Planche T; Basarab M; Bicanic T
BMC Infect Dis; 2023 Nov; 23(1):808. PubMed ID: 37978457
[TBL] [Abstract][Full Text] [Related]
2. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
[TBL] [Abstract][Full Text] [Related]
3. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
[TBL] [Abstract][Full Text] [Related]
5. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
7. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.
Gerver SM; Guy R; Wilson K; Thelwall S; Nsonwu O; Rooney G; Brown CS; Muller-Pebody B; Hope R; Hall V
Clin Microbiol Infect; 2021 Nov; 27(11):1658-1665. PubMed ID: 34481722
[TBL] [Abstract][Full Text] [Related]
8. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
F1000Res; 2022; 11():30. PubMed ID: 35811795
[No Abstract] [Full Text] [Related]
9. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
[TBL] [Abstract][Full Text] [Related]
10. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19.
Puzniak L; Finelli L; Yu KC; Bauer KA; Moise P; De Anda C; Vankeepuram L; Sepassi A; Gupta V
BMC Infect Dis; 2021 Feb; 21(1):227. PubMed ID: 33639862
[TBL] [Abstract][Full Text] [Related]
11. Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020-2021.
Floridia M; Giuliano M; Monaco M; Palmieri L; Lo Noce C; Palamara AT; Pantosti A; Brusaferro S; Onder G;
Antimicrob Resist Infect Control; 2022 May; 11(1):74. PubMed ID: 35598032
[TBL] [Abstract][Full Text] [Related]
12. Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study.
Lingscheid T; Lippert LJ; Hillus D; Kruis T; Thibeault C; Helbig ET; Tober-Lau P; Pfäfflin F; Müller-Redetzky H; Witzenrath M; Zoller T; Uhrig A; Opitz B; Suttorp N; Kramer TS; Sander LE; Stegemann MS; Kurth F
Infection; 2022 Dec; 50(6):1441-1452. PubMed ID: 35420370
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
14. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
15. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
Liu HH; Yaron D; Piraino AS; Kapelusznik L
Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
[TBL] [Abstract][Full Text] [Related]
16. Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality.
Chan XHS; O'Connor CJ; Martyn E; Clegg AJ; Choy BJK; Soares AL; Shulman R; Stone NRH; De S; Bitmead J; Hail L; Brealey D; Arulkumaran N; Singer M; Wilson APR
J Hosp Infect; 2022 Jun; 124():37-46. PubMed ID: 35339638
[TBL] [Abstract][Full Text] [Related]
17. Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults.
Vidaur L; Eguibar I; Olazabal A; Aseguinolaza M; Leizaola O; Guridi A; Iglesias MT; Rello J
Eur J Intern Med; 2024 Jan; 119():93-98. PubMed ID: 37580243
[TBL] [Abstract][Full Text] [Related]
18. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of machine learning-based models for predicting healthcare-associated bacterial/fungal infections among COVID-19 inpatients: a retrospective cohort study.
Wang M; Li W; Wang H; Song P
Antimicrob Resist Infect Control; 2024 Apr; 13(1):42. PubMed ID: 38616284
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?
Owoicho O; Tapela K; Djomkam Zune AL; Nghochuzie NN; Isawumi A; Mosi L
Future Microbiol; 2021 Aug; 16():919-925. PubMed ID: 34319168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
